Biden's new medicine rules have pharmaceutical companies slow-walking new therapies
Saturday, December 23rd 2023, 7:06:59 pm
article
views: 22
Robert Schmad Daily Caller News Foundation Pharmaceutical companies are delaying, or outright canceling, the development of new medicines following new drug rules signed into law by President Joe Biden, Bloomberg reported. The Inflation Reduction Act (IRA), which passed along partisan lines in Congress August 2022, introduced provisions that allow Medicare to negotiate prices for new…
Breaking
ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero...
Ukrainian opposition MP Aleksey Goncharenko has published the text of a purported peace plan reportedly presented to Kiev by the US...
Criminals are targeting shoppers with fake websites, bogus charities and other fraudulent pitches, according to insights from Visa....
Florida cheerleader Anna Kepner was "always happy" and "never complained," her heartbroken mom has said in her first words after the 18-year-old's killing onboard a Carnival cruise ship....
Newsom's office praises Biden's stamina on his 83rd birthday amid health criticisms....
